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ABSTRACT
Upon endoplasmic reticulum (ER) stress, mam-
malian cells induce the synthesis of a transcriptional
activator XBP1s to alleviate the stress. Under un-
stressed conditions, the messenger RNA (mRNA)
for XBP1s exists in the cytosol as an unspliced pre-
cursor form, XBP1u mRNA. Thus, its intron must be
removed for the synthesis of XBP1s. Upon ER
stress, a stress sensor IRE1a cleaves XBP1u
mRNA to initiate the unconventional splicing of
XBP1u mRNA on the ER membrane. The liberated
two exons are ligated to form the mature XBP1s
mRNA. However, the mechanism of this splicing
is still obscure mainly because the enzyme that
joins XBP1s mRNA halves is unknown. Here, we
reconstituted the whole splicing reaction of XBP1u
mRNA in vitro. Using this assay, we showed that,
consistent with the in vivo studies, mammalian
cytosol indeed had RNA ligase that could join
XBP1s mRNA halves. Further, the cleavage of
XBP1u mRNA with IRE1a generated 20,3 0-cyclic
phosphate structure at the cleavage site.
Interestingly, this phosphate was incorporated into
XBP1s mRNA by the enzyme in the cytosol to ligate
the two exons. These studies reveal the utility of
the assay system and the unique properties of the
mammalian cytosolic enzyme that can promote
the splicing of XBP1u mRNA.
INTRODUCTION
The endoplasmic reticulum (ER) is a cellular compartment
where secretory and membrane proteins are folded. When
cells are exposed to stresses such as glucose starvation
and viral infection, unfolded proteins accumulate in the
ER and interfere with ER function. These conditions are
called ER stress. Prolonged ER stress can lead to fatal
damage for living cells. To reduce the ER stress, cells
activate intracellular signaling pathways termed unfolded
protein response (UPR). When a sensor protein of a UPR
system senses unfolded proteins in the ER, it leads to the
activation of the signaling pathway that causes the
upregulation of a subset of proteins including ER molecu-
lar chaperones or to the inhibition of protein synthesis.
Both of them result in the reduction of the ER stress.
In mammalian cells, three UPR branches have been
identiﬁed. One of them is the IRE1a (inositol requiring
enzyme 1)-XBP1 (X-box-binding protein-1) pathway (1,2).
In this pathway, IRE1a is an ER-located transmem-
brane protein that senses the ER stress (3,4). When
IRE1a senses the ER stress, the signal is transduced by
several steps of a reaction cascade, leading to the trans-
lation of a transcriptional activator XBP1s (5–7).
Importantly, under unstressed conditions, the mRNA
for XBP1 exists in the cytosol as a precursor containing
a 26-base intron (this unspliced form of XBP1 mRNA is
called XBP1u mRNA). Thus, the intron must be removed
for the production of XBP1s. Under ER stress, IRE1a
activates its ribonuclease domain and cleaves the XBP1u
mRNA at two speciﬁc sites on the conserved double stem–
loop to initiate the splicing of this transcript. Then, the
two exons are joined by an unknown RNA ligase to form
the mature XBP1s mRNA (spliced XBP1 mRNA). This
splicing reaction creates a translational frameshift to
produce a functional XBP1s transcription factor that
induces the UPR target genes. The splicing occurs only
when IRE1a senses the ER stress, allowing the regulated
activation of this pathway. An analogous system is widely
conserved among eukaryotes. In yeast, Ire1, a yeast
homolog of IRE1a, cleaves the HAC1 mRNA at two
sites during ER stress (8,9). Then, the fragments are
joined by tRNA ligase Rlg1 to express a transcriptional
activator Hac1 (10).
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Like tRNA endonuclease, Ire1 cleaves the HAC1 mRNA,
leaving a 20,3 0-cyclic phosphate terminus at the 30-end of
the 50-exon and a hydroxyl terminus at the 50-end of
the 30-exon (11). Then, two exons are joined in multistep
reactions by Rlg1 as follows. First, Rlg1 opens the 20,
30-cyclic phosphate terminus at the 30-end of the 50-exon
by hydrolyzing it, resulting in the formation of
20-phosphate terminus. Rlg1 also phosphorylates the
hydroxyl terminus at the 50-end of the 30-exon using guano-
sine triphosphate (GTP) or adenosine triphosphate (ATP).
Rlg1 then adenylates the phosphorylated 50-end of the
30-exon using ATP. Following these reaction, the resulting
two RNA fragments are ligated by Rlg1 (Supplementary
Figure S1) (11–13). The ligation by Rlg1 leaves
20-phosphate at the splice junction. This 20-phosphate is
removed by a 20-phosphotransferase Tpt1 (14).
In contrast to the mechanism of the HAC1 mRNA
splicing, that of XBP1u mRNA splicing is only poorly
understood. This is partly due to the lack of our know-
ledge on the enzyme that ligates the two IRE1a-cleaved
fragments of XBP1u mRNA to form the XBP1s mRNA.
Here, we show that the whole splicing reaction of the
XBP1u mRNA can be reconstituted in vitro. This system
allowed us to study the properties of the XBP1u mRNA
splicing in vitro.
MATERIALS AND METHODS
Plasmid construction and recombinant protein expression
To generate the plasmid pBS-hXBP1u which was used
for the in vitro transcription of the unspliced XBP1,
the 0.27-kb KpnI–BglII fragment of pCAX-F-
XBP1DBD-venus (15) was cloned into the KpnI,
BamHI sites of pBluescript II SK(–). To construct the
plasmid IVT-SL85 which was utilized for the synthesis
of SL85 RNA, a DNA fragment encoding SL85
RNA under T7 promoter was ampliﬁed using both
SL85-template-sense (50-CTCACTATTAGGGAAGAG
GTCAGTGGTCGGATCTGTTGAGTCCGCAGTACT
CAAACTACGTGTACCTCTGCAGTAGGTACAGGT
CCAGTTATCACCCCTC-30) and SL85-template-
antisense (50-GAGGGGTGATAACTGGACCTGTACC
TACTGCAGAGGTACACGTAGTTTGAGTACTGCG
GACTCAACAGATCCGACCACTGACCTCTTCCCT
AATAGTGAG-30) as a template and both SL85-sense
(50-CGGGATCCCGCAGTAATACGACTCACTATTA
GGGAAGAGGTCAGTG-30) and SL85-antisense
(50-GGAATTCCGATATCGAGGGGTGATAACTGGA
CCTGTACC-30) as primers. The resulting DNA fragment
was cut with BamHI and EcoRI in primers (the restriction
sites are shown in bold letters) and ligated into the cor-
responding restriction sites of pEBFP (Clontech).
Recombinant IRE1a was expressed in SF9 cells and
puriﬁed as previously described (16).
In vitro RNA transcription
To prepare the unspliced XBP1 RNA (XBP1u RNA),
pBS-hXBP1u was cleaved with SpeI, puriﬁed by
phenol–chloroform extraction and ethanol precipitation,
and then used as a template for the in vitro transcription
reaction. The reaction was performed at 30 C for 1h with
the Riboprobe systems (Promega) using T7 RNA poly-
merase. To synthesize radio-labeled SL85 RNA, the
IVT-SL85 plasmid was cleaved with EcoRV and used as
a template for the in vitro transcription reaction (see
above). To speciﬁcally radio-label the RNA, the reaction
was performed in the presence of [a-
32P]CTP (3000Ci/
mmol). All in vitro transcribed RNAs were puriﬁed
using RNAiso Plus (TaKaRa) and resuspended in water.
Preparation of rabbit erythrocyte lysate
The rabbits (New Zealand White strain, female) were used
as a source to prepare erythrocyte lysate. Blood from the
rabbits, collected in a heparinized tube, was centrifuged at
120g for 10min at 2 C to remove plasma cells in the super-
natant. The leukocytes and erythrocytes in the pellet
fraction were washed six times by centrifugation at 650g
for 5min with the equal volumes of ice-cold saline buffer
(0.14M NaCl, 1.5mM MgCl2 and 5mM KCl). The
washed cells were then resuspended in the equal volumes
of saline and subjected to centrifugation at 1020g for
15min at 2 C. After aspirating off leukocytes in the super-
natant, erythrocytes in the precipitate were lysed by the
addition of the equal volumes of ice-cold distilled water.
The suspension was centrifuged at 16000g for 18min at
2 C to obtain the supernatant (rabbit erythrocyte lysate)
and to remove the pellet (membranes and cell debris). The
erythrocyte lysate thus obtained was frozen under liquid
nitrogen and stored at  80 C.
In vitro splicing of XBP1u mRNA
The splicing reactions (40ml) were carried out at 30 C for
1h in kinase buffer [20mM HEPES, 10mM Mg(OAc)2
and 50mM KOAc (pH 7.3 at 4 C)] containing XBP1u
RNA (0.05pmol), recombinant IRE1a (2.5pmol), 30ml
cell lysate, 20U RNasin (Promega), 0.25mM DTT,
1.25mM ATP and 0.75mM GTP. After the splicing
reaction, the RNA was puriﬁed using RNAiso Plus
(TaKaRa) and resuspended in water. To detect the
spliced and unspliced XBP1 RNA, we performed
RT-PCR as follows. The spliced product was subjected
to reverse transcription with the Superscript ﬁrst-strand
synthesis system (Invitrogen) using an oligonucleotide
(50-GGATCTTGAATCTGAAGAGTC-30) as a primer.
The resulting cDNA was then subjected to PCR to
amplify the cDNA fragments that represent the spliced
and unspliced XBP1 RNA. A three-step reaction (incuba-
tion at 96 C for 30s; 55 C, 30s; 72 C, 30s) was repeated
for 25 cycles in a reaction mixture (20ml) containing 0.5U
of KAPATaq Extra (KAPA Biosystems), 0.5mM each of
the sense and antisense primers and 0.5ml of the product
form the reverse transcription. The sense and antisense
primers used were 50-GAACCAGGAGTTAAGACA
GC-30 and 50-AGTCAATACCGCCAGAATCC-30. The
ﬁnal RT-PCR products, representing the spliced
and unspliced XBP1 RNA, were separated on a 5%
acrylamide gel and visualized with ethidium bromide.
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efﬁciency per 1mg of the protein. The splicing efﬁciency
was calculated by the following formula: spliced RNA/
(unspliced RNA+spliced RNA). For the analysis of the
data, we used Image Gauge software (Fuji Film).
Partial puriﬁcation of RNA ligase for the XBP1u
mRNA splicing
Ammonium sulfate precipitation. Ten milliliters of rabbit
erythrocyte lysate ( 2500mg of protein) was diluted
3-fold with buffer A [20mM Tris–HCl (pH 8.9 at 4 C),
20% v/v glycerol, 0.2mM ethylenediaminetetraacetic acid
(EDTA), 0.5mM phenylmethanesulfonylﬂuoride PMSF,
0.5mM dithiothreitol (DTT)], to which ammonium
sulfate was added to 45% saturation. The solution was
left for 1h and then centrifuged at 25000g for 30min.
The supernatant was treated again with ammonium
sulfate to 65% saturation, left for 1h, and centrifuged at
25000g for 30min. The precipitate was dissolved in 2.5ml
of buffer A and then passed to a PD-10 column
(GE Healthcare), previously equilibrated with buffer A,
to remove any residual ammonium sulfate and change
the buffer to buffer A.
Mono Q chromatography. The peak fraction from
ammonium sulfate precipitation (precipitate of 45–65%
fraction) was loaded onto a Mono Q HR 5/5 column
(GE Healthcare) previously equilibrated with buffer A.
After washing the column with 10ml of buffer A, the
proteins were eluted by a linear gradient from 0mM to
1M KCl. The fractions (1ml each) were dialyzed for 2h
against buffer A and stored at  80 C. All puriﬁcation
procedures were performed at 4 C.
Synthesis of
32P-labeled SL27
To introduce
32P to the phosphodiester linkage at the
IRE1a cleavage site of the model substrate SL27, an
RNA oligonucleotide (corresponding to the 30-terminal
14nt of SL27: 50-CAGCACUCAGACUA-30; its 30-end
was modiﬁed with amine) was synthesized and its
50-hydroxyl group was phosphorylated with [g-
32P]ATP
(7000Ci/mmol) using T4 polynucleotide kinase (TaKaRa)
to obtain the 30-part of SL27 that was radio-labeled with
32P at the 50-end. After puriﬁcation using RNAiso Plus
(TaKaRa), the
32P-labeled 30-part of SL27 was ligated
with an equal amount of a synthetic RNA oligonucleotide
(corresponding to the 50-terminal 13nt of SL27: 50-UAGU
CUGAGUCCG-30) using T4 RNA ligase (TaKaRa). This
ligation reaction led to the synthesis of SL27 that was
labeled with
32P at the IRE1a cleavage site. For puriﬁca-
tion, the ligation product (SL27) was excised from a
denaturing polyacrylamide gel after electrophoresis and
eluted from the gel slice using RNAiso plus (Takara).
Analysis of the terminal structure of the IRE1a
cleavage product
To study the terminal structure generated by cleavage of
XBP1u mRNA with IRE1a, the SL27 RNA (5000c.p.m.)
was cleaved with 100pmol of recombinant IRE1a at 30 C
for 1h in the kinase buffer (see above) (40ml)
supplemented with 20U of RNasin (Promega), 0.25mM
DTT, 1.25mM ATP and 0.75mM GTP. The
IRE1a-cleaved SL27 was then subjected to the enzymatic
reaction with calf intestine alkaline phosphatase or T4
polynucleotide kinase for 1h at 37 C. The reaction
products were separated by electrophoresis on a 10%
denaturing polyacrylamide gel. The signals were detected
by autoradiography using the BAS 2500 system (Fuji
Film) to examine the susceptibility of
32P at the
IRE1a-cleavage site to the enzymatic treatments.
Removal of
32P from the IRE1a-cleaved SL27, with T4
polynucleotide kinase but not with calf intestine alkaline
phosphatase, indicates that the cleavage by IRE1a creates
20,3 0-cyclic phosphate structure at the 30-end of the
cleavage site.
Discrimination of the two splicing mechanisms
To study the splicing mechanism of XBP1u mRNA, we
radio-labeled the model substrate SL85 by in vitro tran-
scription in the presence of [a-
32P]CTP (see above). The
radio-labeled SL85 RNA was then subjected to in vitro
splicing reaction by incubating the RNA with 20pmol of
recombinant IRE1a, and 30ml of rabbit erythrocyte lysate
at 30 C for 1h in 40ml of kinase buffer supplemented with
20U RNasin (Promega), 0.25mM DTT, 1.25mM ATP
and 0.75mM GTP. For puriﬁcation, the re-ligated
product of SL85 RNA was excised from a denaturing
polyacrylamide gel after electrophoresis and eluted from
the gel slice using RNAiso plus (Takara). The puriﬁed
RNA (15000c.p.m.) was then digested with 200U
of RNase I (Ambion) at 37 C for 3h in a buffer
solution containing 10mM Tris–HCl (pH 7.6) and
0.1M NaCl. To discriminate the two splicing mechan-
isms, the digested products (
32P-labeled nucleotide
30-monophosphates) (3000c.p.m.) were separated by
two-dimensional thin-layer chromatography on PEI cellu-
lose (Merck), and visualized and quantiﬁed by autoradi-
ography using the BAS 2500 system and Image Gauge
software (Fuji Film). For the separation, the ﬁrst dimen-
sion was run in solvent A (isobutyric acid/saturated
ammonia/water [66/1/3]), and the second dimension in
solvent B (isopropanol/concentrated HCl/water [68/18/
14]) (17). 30-monophosphorylated nucleotide standards
were visualized by ultraviolet light.
RESULTS
Reconstitution of the splicing reaction of XBP1u
mRNA in vitro
To study the splicing mechanism of XBP1u mRNA,
we wanted to develop an in vitro assay for the splicing
reaction of XBP1u mRNA. Although the RNA ligase
for the splicing reaction of XBP1u mRNA has not been
identiﬁed, recent results indicate that XBP1u mRNA
splicing likely occurs in the cytosol (18, 19, unpublished
data by Shinya,S. and Kohno,K.). Thus, we have used the
erythrocyte lysate as a source of ligase activity, because
erythrocytes of mammals do not contain the nucleus (20).
To reconstitute the reaction, we incubated the in vitro
transcribed XBP1u RNA, recombinant human IRE1a
Nucleic Acids Research, 2011,Vol.39, No. 12 5247that cleaves the XBP1u RNA at the correct site (16), and
rabbit erythrocyte lysate, a source of the RNA ligase.
After incubation, the reaction products were subjected
to RT-PCR using primers that can amplify both the
XBP1u and XBP1s RNA. The RT-PCR products were
then separated by acrylamide gel electrophoresis and
visualized with ethidium bromide (Figure 1A). The
addition of the rabbit erythrocyte lysate to the reaction
caused the appearance of a fast migrating band that cor-
responds to the XBP1s RNA (Figure 1A, lanes 2–5). The
determination of the nucleotide sequence of the fast
migrating band revealed that this band represents the
RT-PCR product of the XBP1u RNA that has been
spliced at the correct position (Figure 1B). Thus, we
have successfully reconstituted the splicing reaction of
XBP1u mRNA in vitro.
In yeast, ATP and GTP play important roles in the
ligation of HAC1 mRNA: Rlg1, the ligase for the
splicing of HAC1 mRNA, requires GTP or ATP for the
phospharylation of the 50-terminus of 30-exon and ATP
for the subsequent adenylation of the 50-phosphorylated
terminus of 30-exon during its catalysis (Supplementary
Figure S1) (11). We thus investigated the nucleotide re-
quirements for the splicing of XBP1u mRNA. To
remove the endogenous nucleotide, we collected proteins
by ammonium sulfate precipitation. The RNA ligase
activity was enriched in the precipitate of the 45–65%
saturated fraction (Figure 2A, 45–65% ppt). Thus, we
used this fraction to analyze the nucleotide requirements.
The results (Figure 2B) show that both ATP and GTP can
stimulate this ligase activity.
Partial puriﬁcation of RNA ligase for XBP1u mRNA
splicing
This splicing assay allowed us to partially purify the RNA
ligase that can promote XBP1u mRNA splicing. In the
ﬁrst step of puriﬁcation, we fractionated proteins by
ammonium sulfate precipitation as described above
(Figure 2A). The active fraction (Figure 2A, 45–65%
ppt) was separated by anion exchange chromatography
on a Mono Q column. Surprisingly, when we analyzed
the ligase activity in the resulting Mono Q fractions, we
could not detect the peak of activity (Figure 3A). This
result raised a possibility that two or more fractions
might be necessary to reconstruct the ligation activity.
To test this possibility, we mixed every one fraction
with another and measured the RNA ligase activity of
the combined two fractions using the splicing assay
(Figure 3B and C). Remarkably, when two of the Mono
Q fractions (fractions 5 and 8) were mixed, a peak of ligase
activity was recovered (Figure 3B, lane 10 and Figure 3C,
Figure 1. Reconstitution of the XBP1u mRNA splicing in vitro.( A) Splicing assay. The reaction mixtures (40ml) contained recombinant human
IRE1a (rIRE1a), transcribed XBP1u RNA (XBP1u) and rabbit erythrocyte lysate (REL). After the reaction, the relative ligase activity was examined
as described in ‘Materials and Methods’ section. The amounts of REL added to the reactions are: 0mg (lane 1), 25mg (lane 2), 125mg (lane 3), 250mg
(lane 4), 500mg (lane 5). The positions of the RT-PCR products representing the XBP1u (U) and XBP1s (S) RNAs are indicated. (B) Determination
of the nucleotide sequence of the band that corresponds to the XBP1u (U) and XBP1s (S) RNAs in (A). The sequence around the splice junction
revealed that two halves of XBP1s RNA were joined at the correct position after the in vitro splicing reaction. Numbers in (B) denote nucleotide
positions. The ﬁrst A of the initiation methionine codon is set at 1.
5248 Nucleic Acids Research, 2011,Vol.39, No. 12lane 8). The activity was much higher than those of the
original individual fractions. These results suggest that the
RNA ligase for XBP1u mRNA splicing may include at
least two components.
To further characterize the two fractions (fractions 5
and 8), we studied the nucleotide requirements for the
ligation reaction promoted by these fractions. The
splicing reaction using the mixed-Mono Q fractions was
stimulated by ATP or GTP (Supplementary Figure S2).
This ﬁnding is consistent with the result obtained with the
reaction using the ammonium sulfate-precipitated rabbit
erythrocyte lysate. We also studied the sensitivity of these
fractions to heat treatment. Upon heat treatment, both the
rabbit erythrocyte lysate and two Mono Q fractions (frac-
tions 5 and 8) lost their ability to promote the splicing of
XBP1u mRNA (Supplementary Figure S3). Thus, some
factors involved in the reaction are heat-labile.
IRE1a generates 20,3 0-cyclic phosphate terminus
We could not further purify the RNA ligase, possibly
because of the low abundance of the enzyme in vivo.
Thus, we next proceeded to examine the mechanism of
XBP1u mRNA splicing in vitro. Biochemical studies
have revealed that mammalian cells have two distinct en-
zymatic pathways for the ligation of the 50- and 30-exons of
tRNA (Figure 4A). One is the yeast-like pathway that
joins these tRNA halves by using a new phosphate
derived from the phosphorylated 50-end of the 30-exon at
the splice junction (50-P pathway) (21). Another is the
pathway that directly ligates the 20,3 0-cyclic phosphate
at the 30-end of the 50-exon and 50-hydroxyl terminus of
the 30-exon to form a 30,5 0-phosphodiester bond (30-P
pathway) (22,23). To know which mechanism is
employed for the XBP1u mRNA splicing, we have per-
formed the following experiments.
As a ﬁrst step toward the understanding of the ligation
mechanism, we determined the terminal structures of 50-
and 30-exons generated after cleavage of XBP1u mRNA
by IRE1a. It has been known that cleavage of precursor
RNAs by tRNA endonuclease and yeast Ire1 generates 20,
30-cyclic phosphate terminus at the 30-end of the 50-exon
and 50-hydroxyl terminus at the 50-end of the 30-exon (11).
However, the terminus structures generated by cleavage of
XBP1u mRNA by mammalian IRE1a have not been
studied. To study their structures, we synthesized a radio-
active stem–loop substrate (SL27) that had an [a-
32P]
labeled phosphodiester linkage only at the cleavage site
(Figure 4B). After cleaving SL27 RNA with recombinant
IRE1a, we studied the terminal structures of the cleaved
products using calf intestine alkaline phosphatase (CIAP)
and T4 polynucleotide kinase (T4 PNK). Importantly,
T4 PNK, but not CIAP, can hydrolyze 20,3 0-cyclic phos-
phate and release the phosphate group from the remaining
RNA moiety (24). This difference in the activities of
these two enzymes has been used to study the terminal
structures of the products of RNA cleaving enzymes
(Figure 4C).
To analyze the terminal structure, we ﬁrst cleaved the
labeled SL27 RNA with IRE1a. As expected, the cleavage
reaction yielded a smaller RNA fragment that gives a
radioactive signal (Figure 4D, lane 2), indicating that the
latter fragment represents the IRE1a-cleaved fragment
with
32P. We next studied the susceptibility of the
32P-labeled phosphate moiety in the fragment to each of
the two enzymes. Remarkably, T4 PNK successfully
removed
32P from the fragment (Figure 4D, lane 4).
Figure 2. Nucleotide requirements for the ligase activity. (A)T o
remove nucleotides from the rabbit erythrocyte lysate (REL) and par-
tially purify the ligase for XBP1u mRNA splicing, we performed
ammonium sulfate precipitation. REL was ﬁrst saturated to 45%
with ammonium sulfate and the protein precipitate (0–45% ppt) was
collected by centrifugation. The resulting supernatant was then
saturated to 65% with ammonium sulfate and the precipitate
(45–65% ppt) was obtained by centrifugation. Each of these protein
precipitates was dissolved in buffer A and dialyzed against the same
buffer. The samples were then subjected to the splicing assay and their
relative ligation activity was calculated as described in ‘Material and
Methods’ section. U and S indicate the positions of the RT-PCR
products representing the XBP1u and XBP1s RNAs. (B) After
cleaving the XBP1u RNA with IRE1a, the cleaved product was
puriﬁed and subjected to in vitro splicing reaction with the 45–65%
fraction from the ammonium sulfate precipitation of REL. The
activity observed in the presence of both 1.25mM ATP and 0.75mM
GTP was taken as 100%. Error bars indicate standard deviations from
the average of three independent experiments.
Nucleic Acids Research, 2011,Vol.39, No. 12 5249However, CIAP failed to do so (Figure 4D, lane 3).
This result indicates that IRE1a generates 20,3 0-cyclic
phosphodiester terminus, the same structure generated
by cleavage of RNA with Ire1 or tRNA endonuclease.
The 30-phosphate of 50-exon is incorporated into the
XBP1s mRNA
To further study the mechanism of ligation step of the
XBP1u mRNA splicing, we next asked whether the
enzyme uses the 50-P pathway or the 30-P pathway. The
difference between these two models is that phosphate at
the 20,3 0-cyclic phosphate structure at the 30-end of the
50-exon (Figure 5A, stage 2) remains in the ﬁnal spliced
product in the 30-P pathway but not in the 50-P pathway
(Figure 5A, stage 3). Thus, to distinguish between two
reaction mechanisms, we radio-labeled this phosphate
with
32P and then examined whether
32P stays at the
junction after the splicing reaction (Figure 5A, stage 3).
To radiolabel the phosphate at the cleavage sites in the
model substrate SL85 (Figure 5B), we performed in vitro
transcription in the presence of [a-
32P]CTP (Figure 5A,
stage 1). The labeled transcript was then subjected to the
in vitro splicing reaction, and the resulting spliced product
was puriﬁed. To examine the presence or absence of
32Pa t
the splice junction, we treated the spliced product with
ribonuclease I (RNase I) that cleaves after all four bases,
leading to the formation of nucleotide 30-monophosphate
(Figure 5A, stage 4). Importantly, after digestion of the
spliced product with RNase I,
32P at the splice junction
will be present in guanosine 30-monophosphate only when
the reaction proceeds via the 30-P pathway (stage 4). Thus,
we examined the presence or absence of
32P-labeled
guanosine 30-monophosphate (Gp) in the resulting nucleo-
tides by separating them by two-dimensional thin-layer
chromatography (stage 4). The presence of
32P-labeled
Gp spot (G*p) in the ﬁnal product will support the 30-P
mechanism for the XBP1u mRNA splicing (stage 4).
It should be noted that, to facilitate the analysis, we
have made several changes in the model substrate. The
model substrate contains 85-nt sequence corresponding
Figure 3. Efﬁcient splicing of XBP1u mRNA requires two Mono Q fractions. (A) RNA ligase after ammonium sulfate precipitation was separated
by anion-exchange chromatography on a Mono Q column. The total of 10 fractions, obtained by elution with buffer A containing KCl, were
subjected to the splicing assay (lanes 3–12). Lanes 1 and 2: assay with REL and the fraction before anion-exchange chromatography. (B) We mixed
every one fraction with another and measured the RNA ligase activity of the combined two fractions using the splicing assay. The combinations of
fractions in the assays shown in this panel are: fractions 5 and 5 (lane 3), fractions 5 and 1 (lane 4), fractions 5 and 2 (lane 5), fractions 5 and 3 (lane
6), fractions 5 and 4 (lane 7), fractions 5 and 6 (lane 8), fractions 5 and 7 (lane 9), fractions 5 and 8 (lane 10), fractions 5 and 9 (lane 11) and
fractions 5 and 10 (lane 12). (C) The combinations of fractions in the assays shown in this panel are: fractions 8 and 8 (lane 3), fractions 8 and 1
(lane 4), fractions 8 and 2 (lane 5), fractions 8 and 3 (lane 6), fractions 8 and 4 (lane 7), fractions 8 and 5 (lane 8), fractions 8 and 6 (lane 9), fractions
8 and 7 (lane 10), fractions 8 and 9 (lane 11) and fractions 8 and 10 (lane 12).
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(Figure 5B). In the original sequence (Supplementary
Figure S4), there are eight GC sequences in addition to
the two GC sequence at the cleavage sites. Thus, guano
sine at these eight GC positions will also generate
32P-labeled guanosine 30-monophosphate when the
spliced RNA is digested with RNase I, which makes it
difﬁcult to evaluate whether the phosphate at the splice
junction still retains
32P or not. To overcome this problem,
we removed all GC sequences from the original XBP1u
mRNA sequence except the two GC sequences at the
IRE1a cleavage sites, by introducing substitution muta-
tions as illustrated in the Supplementary Figure S4. To
do this, the substitutions were introduced in a way that
allows the formation of the putative secondary structure
of the molecule (Supplementary Figure S4).
The separation of the ﬁnal products by two-dimensional
thin-layer chromatography (Figure 5A, stage 4) revealed
the presence of
32P-derived radioactivity in the Gp spot
(Figure 5C). We determined the ratio of radioactivity in
each spot (A*p, G*p, C*p and U*p) relative to the total
radioactivity. These values were in good agreement with
the values expected if the splicing occurs via the 30-P
pathway (see the legend to Figure 5C). Importantly, we
detected a reasonable amount of radioactivity in Gp spot.
The latter value should be zero if the splicing occurs via
the 50-P pathway. These ﬁndings led us to conclude that
the cytosol of mammalian cells contains an RNA ligase
Figure 4. Determination of the terminal structure generated by speciﬁc cleavage of XBP1u mRNA by IRE1a.( A) Proposed mechanisms for the
ligation of RNA fragments during RNA splicing in mammalian cells. (B) Predicted secondary structure of the region surrounding the IRE1a
cleavage sites of the human XBP1u mRNA (left) and schematic representation of RNA substrate (SL27) used in this assay (right). SL27
contains the stem–loop structure of the 50-splice site ﬂanked by four nucleotide sequences on both ends. The latter sequences were added to stabilize
its stem structure. Black triangles mark the sites of speciﬁc cleavage by IRE1a. The phosphate group radio-labeled with
32P is indicted by *p. (C)
Scheme for determining the terminal structure generated by speciﬁc cleavage of XBP1u mRNA by IRE1a. T4 polynucleotide kinase (T4 PNK), but
not calf intestine alkaline phosphatase (CIAP), can remove phosphate from the 20,3 0-cyclic phosphate structure (here abbreviated G>p). Thus, this
assay allows for the identiﬁcation of 20,3 0-cyclic phosphate at the terminus generated by speciﬁc cleavage of the model substrate by IRE1a.( D) SL27
RNA was cleaved by rIRE1a for 1h at 30 C, and then incubated with CIAP or T4 PNK for additional 1h at 37 C. The reaction products were
separated by electrophoresis on a 10% denaturing polyacrylamide gel and detected by autoradiography. The positions of the model substrate SL27
and the IRE1a cleaved SL27 fragment containing the 20,3 0-cyclic phosphate structure are indicated on the left.
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pathway.
DISCUSSION
The splicing of XBP1u mRNA proceeds via two steps of
reactions. In the ﬁrst step, XBP1u mRNA is cleaved in the
cytosol by the endonuclease IRE1a that has been
activated by ER stress. This reaction liberates the 50-
and 30-exons from the precursor mRNA. In the second
step, the two exons are ligated to form the XBP1s
mRNA. However, the mechanism of this unconventional
splicing is still unclear, especially in the ligation step,
because the ligase required for the XBP1u mRNA
splicing has not been identiﬁed. Here, we have successfully
reconstituted the whole splicing reaction of XBP1u
mRNA in vitro (Figure 1). This assay allowed us to char-
acterize the splicing reaction of XBP1u mRNA in vitro.
Our results reveal the similarities and differences in the
splicing mechanism between the yeast HAC1 mRNA and
the mammalian XBP1u mRNA. It has already been
demonstrated that the cleavage of HAC1 mRNA by
yeast Ire1 generates 20,3 0-cyclic phosphate terminus at
the 30-end of the 50-exon. Human IRE1a takes the same
domain structure as yeast Ire1. In addition, its RNase
domain shares 33% sequence identity with that of yeast
Ire1 (25). Yet, how human IRE1a cleaves XBP1u mRNA
remained obscure. Here, we used two RNA processing
enzymes to study the terminal structure of the cleavage
product of XBP1u mRNA with human IRE1a. Our data
clearly show that human IRE1a also generates 20,3 0-cyclic
phosphate terminus at the 30-end of the 50-exon,
illuminating the remarkable similarities between the
yeast Ire1–Hac1 and human IRE1a–XBP1 pathways.
Despite these similarities, our studies also suggest that
the mechanism used by the enzyme in the cytsol of mam-
malian cells to join the two halves of XBP1s mRNA may
be different from the mechanism employed by yeast Rlg1
to ligate the two exons of HAC1 mRNA. In yeast, it
has been established that tRNA ligase Rlg1 is responsible
for the ligation of HAC1 mRNA splicing. For the
ligation, Rlg1 uses a new phosphate derived from the
phosphorylated 50-end of the 30-exon at the splice
junction. However, in mammalian cells, the previous bio-
chemical analysis revealed the existence of two distinct
pathways for the ligation of RNA. They are the yeast-like
Figure 5. Studies on the mechanism of ligation of the two halves of XBP1s mRNA. (A) Scheme for analyzing the ligation mechanism (see text for
detail). The phosphate labeled with
32P is indicated by *p. The 20,3 0-cyclic phosphate structure was abbreviated as >p. Note that RNase I would not
cleave a dinucleotide bond that has a 20-phosphate. Thus, the cleavage of the spliced product with RNase I would yield a speciﬁc set of labeled
nucleotides depending on the mechanism of ligation (stage 4). (B) Schematic representation of RNA substrate (SL85) used in this assay. Note that
the last three nucleotides of SL85 (GAU) originate from the EcoRV restriction site used to linearize the template plasmid for in vitro transcription.
(C) Following in vitro splicing reaction, the ligated product from SL85 RNA was gel-puriﬁed, and digested with RNase I. The resulting nucleotide
monophosphate was separated by two-dimensional thin-layer chromatography to examine the fate of [a-
32P] phosphate at the splice junction. The
positions of nucleotide 30-monophosphate (Ap, Gp, Cp and Up) were indicated. The ratio of radioactivity in each of the nucleotide
30-monophosphate (Ap, Gp, Cp and Up) to the total radioactivity (the sum of their radio-activities) was determined. The actual values are:
0.119±0.006 (for Ap), 0.078±0.006 (Gp), 0.359±0.004 (Cp) and 0.447±0.007 (Up). The numbers represent mean±SD of three independent
experiments. We also calculated the values expected if the splicing of the model substrate SL85 occurs via the 30-P pathway: 0.133 (for Ap), 0.0667
(Gp), 0.333 (Cp) and 0.467 (Up). The actual values were in good agreement with the expected values.
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pathway (see above) (Figure 4A). Using our system, we
have found that the RNA ligase in the cytosol of mam-
malian cells can join the two halves of XBP1s mRNA
using the 30-P pathway (Figure 5C).
Importantly, the ﬁnal product of ligation differs
between the two pathways. With the 50-P pathway,
RNA ligase leaves a 20-phosphate at the splice junction;
thus, this 20-phosphate is removed by a 20-phospho-
transferase. With the 30-P pathway, however, RNA
ligase does not leave a 20-phosphate at the splice
junction. The yeast RNA ligase Rlg1 leaves 20-phosphate
at the splice junction after ligation of the HAC1 mRNA
(11), necessitating an enzyme catalyst that removes this
phosphate to complete the HAC1 mRNA splicing. In
yeast, this reaction is performed by 20-phosphotransferase
Tpt1. Surprisingly, the deletion of Trpt1, the mammalian
homolog of Tpt1, from the mouse chromosome, has no
effect on the XBP1u mRNA splicing (26). Here, we
showed that the mammalian cytosol has an enzyme that
uses the 30-P pathway to ligate the two halves of XBP1s
mRNA. Since this reaction does not leave 20-phosphate at
the splicing junction, our ﬁnding can explain the
non-essentiality of the 20-phosphotransferase TRPT1 for
the splicing of XBP1u mRNA in mouse.
Notably, we observed that both ATP and GTP
stimulated the ligation of the XBP1s mRNA halves in
the reaction catalyzed by the enzyme in the mammalian
cytosol. This is in contrast to the situation in yeast where
ATP works as an essential cofactor for the ligation of two
HAC1 mRNA halves in the reaction catalyzed by Rlg1
(Supplementary Figure S1). Importantly, ATP is essential
for the adenylation step of HAC1 mRNA ligation.
However, this step will not be required if the reaction
catalyzed by the mammalian cytosolic enzyme proceeds
via the 30-pathway as has been demonstrated in this
study. Thus, the difference in the requirements for nucleo-
tides observed between Rlg1 and the enzyme in the mam-
malian cytosol may reﬂect their respective mechanistic
properties.
Interestingly, our results suggested that the RNA ligase
includes at least two components (Figure 3B and C). Both
of them were heat-labile (Supplementary Figure S3).
However, the reason for the necessity of the two Mono
Q fractions for the efﬁcient ligation of the XBP1s mRNA
halves remains unclear. One possibility is that one of the
components is used to speciﬁcally recognize the two exons
and deliver them to a general RNA ligase. Since IRE1a
not only cleaves XBP1u mRNA for splicing but also
cleaves other mRNA for their degradation (27–29). The
promiscuous ligation of the latter RNA fragments will
yield unwanted forms of mRNA and thus would be un-
favorable for the cells. To avoid the latter reaction, it is
possible that the cells may have evolved an adapter that
connects the two exons and the RNA ligase.
The RNA ligase for the splicing of XBP1u mRNA has
not been identiﬁed. Our current ﬁndings suggest that there
could be two reasons for it. First, the ligation has been
thought to occur via the 50-P pathway as yeast Rlg1
uses this mechanism. Here, we showed evidence that the
XBP1 ligase, instead, may use the 30-P pathway. This
discrepancy may have caused difﬁculty in the search for
the enzyme. Second, our results suggest that two or more
components may be required for the ligation of the two
halves of XBP1s mRNA. If this is the case, the simple
overexpression of a cDNA product may not lead to an
increase in the activity of the ligase required for the
XBP1u mRNA splicing. Our development of the assay
system will open up a doorway for the identiﬁcation of
the RNA ligase involved in the XBP1u mRNA splicing.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
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